GLP-1 Research Tracker

Every clinical trial and published study on semaglutide, tirzepatide, and next-generation GLP-1 medications — curated with plain-language summaries.

234 studies tracked·6 compounds covered·Updated Jul 2026

Has results

Management of Obesity in Psoriasis Consultations.

tirzepatide

Dermatology and therapyFeb 2026

Steatotic liver disease and liver transplantation: Candidate selection and post-transplant management.

JHEP reports : innovation in hepatologyFeb 2026

Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics.

BiomedicinesJan 2026

Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.

semaglutidetirzepatideliraglutideorforglipronretatrutide

European journal of medical researchJan 2026

Preserved Ejection, Lost Rhythm: A Narrative Review of the Pathophysiology and Management of Heart Failure with Preserved Ejection Fraction and Concomitant Atrial Fibrillation.

Journal of clinical medicineJan 2026

Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia.

semaglutidetirzepatideliraglutide

Skin appendage disordersJan 2026

Emerging and Established Pharmacotherapies for Smoking Cessation: A Review.

Cardiology in reviewJan 2026

The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: a narrative review.

tirzepatide

Frontiers in endocrinologyJan 2026

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review.

semaglutide

Acta gastro-enterologica BelgicaJan 2026

Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A Review.

CureusJan 2026

Acute Pancreatitis Associated With Semaglutide in a Patient With Multimorbidity: A Case Report.

semaglutide

CureusJan 2026

Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women.

semaglutidetirzepatide

AACE endocrinology and diabetesJan 2026

Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders.

semaglutidetirzepatide

Diabetes, metabolic syndrome and obesity : targets and therapyJan 2026

A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management.

semaglutidetirzepatide

Diabetes, metabolic syndrome and obesity : targets and therapyJan 2026

Challenges in the management of obesity.

Journal of clinical lipidologyJan 2026

Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022-2025).

semaglutidetirzepatide

CureusJan 2026

Comparative Analysis of Glucagon Receptor Agonists vs. Resmetirom in MASLD and MASH: Network Meta-Analysis of Clinical Trials.

survodutide

Endocrinology, diabetes & metabolismJan 2026

Investigating the Link Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Non-arteritic Ischemic Optic Neuropathy: A Case Report of Semaglutide-Induced Optic Neuropathy.

semaglutide

CureusJan 2026

Phase 3

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

survodutide

Diabetes, obesity & metabolismJan 2026

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.

retatrutide

Diabetes, obesity & metabolismJan 2026

Load more studies →

GLP-1 Research Tracker

Management of Obesity in Psoriasis Consultations.

Steatotic liver disease and liver transplantation: Candidate selection and post-transplant management.

Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics.

Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.

Preserved Ejection, Lost Rhythm: A Narrative Review of the Pathophysiology and Management of Heart Failure with Preserved Ejection Fraction and Concomitant Atrial Fibrillation.

Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia.

Emerging and Established Pharmacotherapies for Smoking Cessation: A Review.

The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: a narrative review.

GLP-1 receptor agonist-associated eosinophilic duodenitis presenting as a bowel obstruction : a case report and literature review.

Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A Review.

Acute Pancreatitis Associated With Semaglutide in a Patient With Multimorbidity: A Case Report.

Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women.

Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders.

A Clinical Comprehensive Evaluation of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes Management.

Challenges in the management of obesity.

Comparative Gynecological Safety of the Dual GIP/GLP-1 Receptor Agonist Tirzepatide vs. the GLP-1 Receptor Agonist Semaglutide: A Real-World Pharmacovigilance Analysis (2022-2025).

Comparative Analysis of Glucagon Receptor Agonists vs. Resmetirom in MASLD and MASH: Network Meta-Analysis of Clinical Trials.

Investigating the Link Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Non-arteritic Ischemic Optic Neuropathy: A Case Report of Semaglutide-Induced Optic Neuropathy.

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.

Get Weekly Research Updates